In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Accuray Inc.

www.accuray.com

Latest From Accuray Inc.

Market Intel: Rivals Catching Up To Intuitive Surgical In Fast-Growing, Fast-Innovating Robotic-Assisted Devices Market

The global market for robotically assisted systems (RAS) is expected to reach $5.3bn by 2021, a CAGR of 11.7%. Meddevicetracker expects this hot market, long-dominated by Intuitive Surgical's da Vinci systems, to see rising competition from innovative companies developing robotic systems that are smaller, portable and less costly and offer surgeons innovative features that allow them to perform even more precise and user-friendly, complex surgeries. In this feature, we'll take a closer look at the overall market, highlighting the competitive landscape as well as limiters and growth opportunities. We'll also take a deep dive into RAS systems and their applications. Surgeons of various specialties provide key insights about the pros and cons of different systems.

Surgical Procedures Innovation

CyberHeart Takes Non-invasive Approach To AF Ablation

CyberHeart Inc. is developing a non-invasive approach to cardiac dysrhythmia ablation by adapting technology from CyberKnife, the radiosurgery system for cancer treatment. Current clinical trials are examining the use of CyberHeart not only for atrial fibrillation (AF) treatment, but also for ventricular tachycardia, for which a US pivotal trial is scheduled for early 2017.

StartUps and SMEs Cardiovascular

Global Radiation Therapy Systems Market Expected to Reach $5.6B by 2020

Although immunotherapy and other cutting-edge technologies have dominated the spotlight in cancer treatment over the last several years, the use of radiation therapy is rapidly increasing as physicians look to this non-invasive, cost-effective treatment to address a broad and growing number of cancers. Valued at nearly $4.3 billion in 2015, the global radiation therapy market is growing at a CAGR of 5.5%, and is projected to reach $5.6 billion by 2020, according to a recent report from Medtech Insight.

Medical Device Innovation

Intuitive’s da Vinci: Will Familiarity Breed Success?

Robotic soft-tissue MIS pioneer Intuitive Surgical continues to advance its offering in this disruptive area of medical technology. Having weathered an adverse incident-related storm, it is putting efforts into driving OUS business, broadening surgical applications, and convincing the doubters about robotic surgery’s place and role in the catalog of care delivery.

Medical Device Germany
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Accuray Inc.
  • Senior Management
  • Joshua H Levine, Pres. & CEO
    Lionel Hadjadjeba, SVP, Chief Commercial Officer
  • Contact Info
  • Accuray Inc.
    Phone: (408) 716-4600
    1310 Chesapeake Terrace
    Sunnyvale, CA 94089
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register